William W. Freimuth

Plus aucun poste en cours

Consumer Services

Health Technology

Anciens postes connus de William W. Freimuth

Sociétés	Poste	Début	Fin
Human Genome Sciences, Inc. Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.	Directeur Technique/Scientifique/R&D	15/04/2009	22/08/2011
	Corporate Officer/Principal	22/08/2011	01/10/2012
Pharmacia & Upjohn, Inc.	Corporate Officer/Principal	-	-

State University of New York at Buffalo	Doctorate Degree
Michigan State University	Doctorate Degree
University of Michigan	Undergraduate Degree

Internationale

Etats-Unis

Opérationnelle

Doctorate Degree	2
Corporate Officer/Principal	2
Chief Tech/Sci/R&D Officer	1

Sectorielle

Consumer Services	4
Health Technology	3

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Entreprise privées	2
Human Genome Sciences, Inc. Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.	Health Technology
Pharmacia & Upjohn, Inc.	Health Technology

Entreprise privées

Health Technology

Pharmacia & Upjohn, Inc.

Health Technology